Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (181-190 of 484) with videos related to

Pageof 49
Sort By:
Plos One|October 10, 2018
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trialJavier Hernandez, Jonathan Gelfond, Martin Goros, et al.
European Urology|March 31, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons, Jeannette M Schenk, Kathryn B Arnold, et al.
Urologic Oncology|September 24, 2013
Validation of copy number variants associated with prostate cancer risk and prognosisAugust Blackburn, Desiree Wilson, Jonathan Gelfond, et al.
The Journal of Urology|March 17, 2016
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate CancerDonna Pauler Ankerst, Jonathan Gelfond, Martin Goros, et al.
Urology|May 10, 2011
Trends and co-trends of prostate-specific antigen and body mass index in a screened populationDonna P Ankerst, Brad H Pollock, Yuanyuan Liang, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 31, 2011
Fast T2*-weighted MRI of the prostate at 3 TeslaRulon L Hardman, Fadi El-Merhi, Adam J Jung, et al.
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
European Urology|September 1, 2015
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEdwin E Morales, Sonja Grill, Robert S Svatek, et al.
Journal of Biomedical Informatics|May 20, 2015
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculatorsAndreas N Strobl, Andrew J Vickers, Ben Van Calster, et al.
The Journal of Urology|January 13, 2006
Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black menJavier Hernández, Ivana Balic, Teresa L Johnson-Pais, et al.
Pageof 49

Showing results (181-190 of 484) with videos related to

Sort By:
Pageof 49
Plos One|October 10, 2018
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trialJavier Hernandez, Jonathan Gelfond, Martin Goros, et al.
European Urology|March 31, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons, Jeannette M Schenk, Kathryn B Arnold, et al.
Urologic Oncology|September 24, 2013
Validation of copy number variants associated with prostate cancer risk and prognosisAugust Blackburn, Desiree Wilson, Jonathan Gelfond, et al.
The Journal of Urology|March 17, 2016
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate CancerDonna Pauler Ankerst, Jonathan Gelfond, Martin Goros, et al.
Urology|May 10, 2011
Trends and co-trends of prostate-specific antigen and body mass index in a screened populationDonna P Ankerst, Brad H Pollock, Yuanyuan Liang, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 31, 2011
Fast T2*-weighted MRI of the prostate at 3 TeslaRulon L Hardman, Fadi El-Merhi, Adam J Jung, et al.
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
European Urology|September 1, 2015
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEdwin E Morales, Sonja Grill, Robert S Svatek, et al.
Journal of Biomedical Informatics|May 20, 2015
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculatorsAndreas N Strobl, Andrew J Vickers, Ben Van Calster, et al.
The Journal of Urology|January 13, 2006
Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black menJavier Hernández, Ivana Balic, Teresa L Johnson-Pais, et al.
Pageof 49